Floatz logo

Sodium Selenite

Lymphedema

University Health Network, TorontoSmall moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
89/ 100

Competitive context

7 Active assets in the Lymphedema cohort.

Asset / SponsorPhaseRating
Pycnogenol
National Center for Complementary and Integrative Health (NCCIH)
Phase 2B
TACROLIMUS
Odense University Hospital
Phase 2/3B
Lymfactin®
Herantis Pharma Plc.
Phase 2B
Pentoxifylline
M.D. Anderson Cancer Center
Phase 2B
PRAVASTATIN
M.D. Anderson Cancer Center
Phase 2CCC

View all 17 →

Same molecule, other indications

Sodium Selenite is also rated in:

breast neoplasmDormant
CCC
Indicative ·
51 / 100
View asset →
plasmacytomaDormant
CC
Indicative ·
47 / 100
View asset →
hormone-resistant prostate carcinomaDormant
CC
Indicative ·
47 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →